Dupixent (dupilumab) is given by injection every two weeks. It was approved to treat patients with nasal polyps and chronic rhinosinusitis ...

FDA OKs 1st Drug for Sinusitis With Nasal Polyps

illustration of sinusitis

Dupixent (dupilumab) is given by injection every two weeks. It was approved to treat patients with nasal polyps and chronic rhinosinusitis -- defined as a prolonged inflammation of the sinuses and nasal cavity, the FDA said.



from WebMD Health https://ift.tt/2Nhtb3r
via IFTTT